← Open Payments lookup

MICHAEL TAWIAH: Open Payments

NPI 1932671575 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,805 in 111 payments from 20 companies in 2025. Trend: 2023 $1,608 · 2024 $1,709 · 2025 $2,805

Food & beverage: $2,805
CompanyPaymentsAmount
Janssen Biotech, Inc.14$403
Madrigal Pharmaceuticals17$363
ABBVIE INC.15$344
Aimmune Therapeutics, Inc.9$265
QOL Medical, LLC6$227
Ipsen Biopharmaceuticals, Inc4$215
Takeda Pharmaceuticals U.S.A., Inc.9$210
Lilly USA, LLC7$150
PFIZER INC.9$142
Phathom Pharmaceuticals, Inc.4$109

Products named: TREMFYA, REZDIFFRA, ZENPEP, Sucraid, IQIRVO, ENTYVIO, LINZESS, XELJANZ.

Industry payments across CT — which companies pay providers there.